Anika Therapeutics, Inc. (NASDAQ:ANIK) Q3 2023 Earnings Call Transcript
Operator: Good evening, ladies and gentlemen, and welcome to Anika's Third Quarter 2023 Earnings Conference Call. All participants' will be in a listen-only mode.
Stay updated with breaking news from Typec Meeting. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Operator: Good evening, ladies and gentlemen, and welcome to Anika's Third Quarter 2023 Earnings Conference Call. All participants' will be in a listen-only mode.
Operator: Welcome to the Minerva Neurosciences First Quarter 2023 Conference Call. At this time, all participants are in a listen-only mode.
Dermata Therapeutics Provides Corporate Update and Reports First Quarter ...
Operator: Ladies and gentlemen, thank you for standing by, and welcome to the Aldeyra Therapeutics Full Year 2022 Financial Results Conference Call.
Regulatory News: OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) (Paris:OSE) today provides a regulatory update on the clinical development plan of Tedopi®, an immunotherapy activating